Clinical trials
Completed Observational Huntington Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 4 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 2 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CHDI Foundation, Inc. | 4 |
| Huntington Study Group | 4 |
| Centre Hospitalier Universitaire, Amiens | 2 |
| European Huntington's Disease Network | 2 |
| National Human Genome Research Institute (NHGRI) | 2 |
| Sanguine Biosciences | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Cedars-Sinai Medical Center | 1 |
| Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | 1 |
| General University Hospital, Prague | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Huntington Disease | 39 |
| Parkinson Disease | 7 |
| Alzheimer Disease | 3 |
| Disease | 2 |
| Mental Disorders | 2 |
| Multiple Sclerosis | 2 |
| Multiple System Atrophy | 2 |
| Supranuclear Palsy, Progressive | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Alopecia Areata | 1 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.